Cargando…

High-mobility group A1 proteins may be involved in estrogen receptor status of breast cancer

Detalles Bibliográficos
Autores principales:	Harada, Yoshihiro, Ohe, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798379/ https://www.ncbi.nlm.nih.gov/pubmed/35117745 http://dx.doi.org/10.21037/tcr-20-1921

Ejemplares similares

Estrogen receptor-β: why may it influence clinical outcome in estrogen receptor-α positive breast cancer?
por: Shupnik, Margaret A
Publicado: (2007)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Estrogen as therapy for breast cancer
por: Ingle, James N
Publicado: (2002)

High mobility group box-1 protein – one step closer to the clinic?
por: Mollnes, Tom Eirik
Publicado: (2008)

Unraveling the role of high mobility group box protein 1 in severe trauma
por: Abraham, Edward
Publicado: (2009)

Bringing estrogen receptors under control
por: Horwitz, Kathryn B
Publicado: (1999)

How does the estrogen receptor work?
por: Gross, Jennifer M, et al.
Publicado: (2002)

Should we target “intermediate expression” of HER2 in older estrogen receptor positive patients?
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

Invited Commentary: Role of Estrogen Receptor-α in Regulating Claudin-6 Expression in Breast Cancer Cells
por: Youn, Hyun Jo, et al.
Publicado: (2011)

Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer
por: Lee, Kiwon, et al.
Publicado: (2008)

Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase–estrogen receptor axis
por: Huang, Xing
Publicado: (2019)

Expression of glucosylceramide synthase in invasive ductal breast cancer may be correlated with high estrogen receptor status and low HER-2 status
por: Liu, Jiannan, et al.
Publicado: (2014)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Estrogens and Estrogen Receptor Modulators in Cancer Research and Therapy
por: Treeck, Oliver
Publicado: (2023)

PGRMC1: a new biomarker for the estrogen receptor in breast cancer
por: Craven, Rolf J
Publicado: (2008)

Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs)
por: Schiff, Rachel, et al.
Publicado: (2003)

Do estrogen receptor variants explain the enigma of human birth?
por: Smith, Roger, et al.
Publicado: (2018)

Mobile genetic elements are involved in bacterial sociality
por: Dimitriu, Tatiana, et al.
Publicado: (2015)

Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic?
por: Lakhani, Sunil R, et al.
Publicado: (2010)

Estrogen receptor α is involved in the regulation of ITGA8 methylation in estrogen receptor-positive breast cancer
por: Wu, Jingxun, et al.
Publicado: (2020)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Estrogen Receptor Signaling in Cancer
por: Langdon, Simon P.
Publicado: (2020)

Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents
por: Wang, Guangdi
Publicado: (2020)

New Insights Into Metabolic Regulation via Bifurcated Function of Estrogen Receptor α
por: Wada, Tsutomu, et al.
Publicado: (2013)

Life history theory and breast cancer risk: methodological and theoretical challenges: Response to “Is estrogen receptor negative breast cancer risk associated with a fast life history strategy?”
por: Aktipis, Athena
Publicado: (2016)

Microarray data analysis in neoadjuvant biomarker studies in estrogen receptor-positive breast cancer
por: Luo, Jingqin, et al.
Publicado: (2010)

Molecular Pathways of Estrogen Receptor Action
por: Pakdel, Farzad
Publicado: (2018)

The Role of Estrogen Receptors in Health and Disease
por: Pakdel, Farzad
Publicado: (2023)

Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups
por: Miller, Claire, et al.
Publicado: (2023)

Trends in social mobility depend on the competition between status and money
por: Grusky, David B.
Publicado: (2022)

Using a global proteomic approach to identify proteins affected by estrogen therapy
por: Veenstra, Timothy D
Publicado: (2009)

Intrauterine exposures, pregnancy estrogens and breast cancer risk: where do we currently stand?
por: Lagiou, Pagona
Publicado: (2006)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

Targeting brain estrogen receptor for binge eating
por: Xu, Pingwen, et al.
Publicado: (2015)

Upwardly mobile: Lowered hearing?
por: Menon, UK
Publicado: (2017)

COVID-19 and breast cancer: may the microbiome be the issue?
por: Lasagna, Angioletta, et al.
Publicado: (2020)

Roles for estrogen and progesterone in breast cancer prevention
por: Jerry, D Joseph
Publicado: (2007)

Estrogen Receptor Mutations and Changes in Estrogen Receptor and Progesterone Receptor Protein Expression in Metastatic or Recurrent Breast Cancer
por: Umekita, Yoshihisa, et al.
Publicado: (1998)

Gene expression signature of estrogen receptor α status in breast cancer
por: Abba, Martín C, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_g5ehpfqmc0e307n9dr2uspunkv